A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy

201773 citationsJournal Articlehybrid Open Access

Authors

This study provides Class I evidence that tadalafil does not slow ambulatory decline in 7- to 14-year-old boys with Duchenne muscular dystrophy.

Good health and well-being

Published in: Neurology

Volume 89, Issue 17, pp. 1811-1820

Field-Weighted Citation Impact: 3.69